Navana CNG Limited (DSE:NAVANACNG)

Theseus Pharmaceuticals Revenue

Navana CNG had revenue of 1.17B BDT in the quarter ending March 31, 2025, with 0.41% growth. This brings the company's revenue in the last twelve months to 4.32B, up 9.35% year-over-year. In the fiscal year ending June 30, 2024, Navana CNG had annual revenue of 4.08B, down -0.35%.

• Revenue (ttm): 4.32B
• Revenue Growth: +9.35%
• P/S Ratio: 0.39
• Revenue / Employee: 4.49M
• Employees: 962
• Market Cap: 1.68B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	4.08B	-14.47M	-0.35%
Jun 30, 2023	4.09B	-154.66M	-3.64%
Jun 30, 2022	4.25B	-775.32M	-15.43%
Jun 30, 2021	5.02B	-903.87M	-15.25%
Jun 30, 2020	5.93B	41.43M	0.70%